GCP

Durham, North Carolina, U.S. | April 15, 2026 Precision BioSciences has announced a significant clinical and regulatory milestone with...

ATLANTA, United States, April 7, 2026 Alzamend Neuro, Inc. announced encouraging pharmacodynamic data from its Phase II clinical trial...

CAMBRIDGE, Mass., April 2, 2026 Relay Therapeutics, Inc. announced that it will present initial clinical and preclinical data for...

TAMPA, Fla., March 30, 2026 Concept Medical Inc. (CMI) announced the primary results of the SirPAD randomized controlled trial,...

WOBURN, Mass., April 1, 2026 CanWell Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has granted...

NEW YORK, April 3, 2026 MiNK Therapeutics announced that new Phase II clinical trial data for its investigational iNKT...

CONCORD, Calif., USA — April 2, 2026 Panoramic Health, through its clinical research division Panoramic Science, in collaboration with...

SAN FRANCISCO, CA, March 23, 2026 Siren Biotechnology has announced that the U.S. Food and Drug Administration (FDA) has...

South San Francisco, California, USA | March 22, 2026 IDEAYA Biosciences has announced updated guidance on the anticipated topline...

Copenhagen, Denmark | March 23, 2026 New real-world evidence presented at the AD/PD™ 2026 conference highlights that LEQEMBI® (lecanemab-irmb)...